NEW seminar following the SOA Annual Meeting & Exhibit:
Join world class geneticists, scientists and biostatisticians at the Genetically Informed Risk Assessment Seminar to learn how genetic information and the coming revolution in personalized medicine can be applied to risk assessment and life underwriting. Genetically informed decision making, like it or not, is imposing itself on and becoming a valuable resource in medical care and risk assessment. This seminar will reveal how inexpensive, readily available genetic information can be used, and how it will impact medical care, the life and health insurance industry, and the actuarial profession. Presenters will offer insight into some of the latest advancements.
Target Audience
• Actuaries active in product development, assumption setting for risk selection and valuation of financial risk related to human life, health or behavior, experience studies or analysis, the value of insurance after issue, lifetime payout benefits or longevity research
• individuals involved in the life settlement market
• Underwriters including medical directors
• Insurance company management
• Regulators
Join world class geneticists, scientists and biostatisticians at the Genetically Informed Risk Assessment Seminar to learn how genetic information and the coming revolution in personalized medicine can be applied to risk assessment and life underwriting. Genetically informed decision making, like it or not, is imposing itself on and becoming a valuable resource in medical care and risk assessment. This seminar will reveal how inexpensive, readily available genetic information can be used, and how it will impact medical care, the life and health insurance industry, and the actuarial profession. Presenters will offer insight into some of the latest advancements.
Target Audience
• Actuaries active in product development, assumption setting for risk selection and valuation of financial risk related to human life, health or behavior, experience studies or analysis, the value of insurance after issue, lifetime payout benefits or longevity research
• individuals involved in the life settlement market
• Underwriters including medical directors
• Insurance company management
• Regulators
Comment